PARP Inhibitors and Proteins Interacting with SLX4

por Jordheim, Lars Petter
Publicado 2023

A Proposed Methodology to Deal with the Impact of In Vitro Cellular Matrix on the Analytical Performances of a Targeted Metabolomic LC-HRMS Method

por Guitton, Jérôme, Gavotto, Floriane, Cros-Perrial, Emeline, Jordheim, Lars Petter, Machon, Christelle
Publicado 2023

Characterization of T‐DM1‐resistant breast cancer cells

por Sauveur, Juliette, Conilh, Louise, Beaumel, Sabine, Chettab, Kamel, Jordheim, Lars‐Petter, Matera, Eva‐Laure, Dumontet, Charles
Publicado 2020

Cytosolic 5’-Nucleotidase II Interacts with the Leucin Rich Repeat of NLR Family Member Ipaf

por Cividini, Federico, Tozzi, Maria Grazia, Galli, Alvaro, Pesi, Rossana, Camici, Marcella, Dumontet, Charles, Jordheim, Lars Petter, Allegrini, Simone
Publicado 2015

Cytosolic 5′-Nucleotidase II Silencing in a Human Lung Carcinoma Cell Line Opposes Cancer Phenotype with a Concomitant Increase in p53 Phosphorylation

por Pesi, Rossana, Petrotto, Edoardo, Colombaioni, Laura, Allegrini, Simone, Garcia-Gil, Mercedes, Camici, Marcella, Jordheim, Lars Petter, Tozzi, Maria Grazia
Publicado 2018

Cytosolic 5′-Nucleotidase II Silencing in Lung Tumor Cells Regulates Metabolism through Activation of the p53/AMPK Signaling Pathway

por Pesi, Rossana, Allegrini, Simone, Garcia-Gil, Mercedes, Piazza, Lucia, Moschini, Roberta, Jordheim, Lars Petter, Camici, Marcella, Tozzi, Maria Grazia
Publicado 2021

Neutrophils protect lymphoma cells against cytotoxic and targeted therapies through CD11b/ICAM-1 binding

por Hirz, Taghreed, Matera, Eva-Laure, Chettab, Kamel, Jordheim, Lars Petter, Mathé, Doriane, Evesque, Anne, Esmenjaud, Justine, Salles, Gilles, Dumontet, Charles
Publicado 2017

Cytosolic 5′-Nucleotidase II Is a Sensor of Energy Charge and Oxidative Stress: A Possible Function as Metabolic Regulator

por Pesi, Rossana, Allegrini, Simone, Balestri, Francesco, Garcia-Gil, Mercedes, Cividini, Federico, Colombaioni, Laura, Jordheim, Lars Petter, Camici, Marcella, Tozzi, Maria Grazia
Publicado 2021

The Antitumor Activity of Combinations of Cytotoxic Chemotherapy and Immune Checkpoint Inhibitors Is Model-Dependent

por Grasselly, Chloé, Denis, Morgane, Bourguignon, Aurore, Talhi, Nolan, Mathe, Doriane, Tourette, Anne, Serre, Laurent, Jordheim, Lars Petter, Matera, Eva Laure, Dumontet, Charles
Publicado 2018

Transcriptional and Metabolic Investigation in 5′-Nucleotidase Deficient Cancer Cell Lines

por Cadassou, Octavia, Forey, Prescillia, Machon, Christelle, Petrotto, Edoardo, Chettab, Kamel, Tozzi, Maria Grazia, Guitton, Jérôme, Dumontet, Charles, Cros-Perrial, Emeline, Jordheim, Lars Petter
Publicado 2021

The cytosolic 5′-nucleotidase cN-II lowers the adaptability to glucose deprivation in human breast cancer cells

por Bricard, Gabriel, Cadassou, Octavia, Cassagnes, Laure-Estelle, Cros-Perrial, Emeline, Payen-Gay, Léa, Puy, Jean-Yves, Lefebvre-Tournier, Isabelle, Tozzi, Maria Grazia, Dumontet, Charles, Jordheim, Lars Petter
Publicado 2017

5'-nucleotidase cN-II emerges as a new predictive biomarker of response to gemcitabine/platinum combination chemotherapy in non-small cell lung cancer

por Toffalorio, Francesca, Santarpia, Mariacarmela, Radice, Davide, Jaramillo, Christopher Adrian, Spitaleri, Gianluca, Manzotti, Michela, Catania, Chiara, Jordheim, Lars Petter, Pelosi, Giuseppe, Peters, Godefridus J., Tibaldi, Carmelo, Funel, Niccola, Spaggiari, Lorenzo, de Braud, Filippo, De Pas, Tommaso, Giovannetti, Elisa
Publicado 2018

A systemically administered detoxified TLR4 agonist displays potent antitumor activity and an acceptable tolerance profile in preclinical models

por Chettab, Kamel, Fitzsimmons, Chantel, Novikov, Alexey, Denis, Morgane, Phelip, Capucine, Mathé, Doriane, Choffour, Pierre Antoine, Beaumel, Sabine, Fourmaux, Eric, Norca, Patrick, Kryza, David, Evesque, Anne, Jordheim, Lars Petter, Perrial, Emeline, Matera, Eva-Laure, Caroff, Martine, Kerzerho, Jerome, Dumontet, Charles
Publicado 2023